About Bloomage Biotechnology
Bloomage Biotechnology is a company based in Jinan (China) founded in 1998. The company has 4,440 employees as of December 31, 2024. Bloomage Biotechnology has completed 1 acquisition, including Beijing Yierkang Bioengineering. Bloomage Biotechnology operates in a competitive market with competitors including Fidia Farma, Lifecore, Contipro, Qingdao Kangyuan Pharmaceutica and Altergon Italia, among others.
- Headquarter Jinan, China
- Employees 4440 as on 31 Dec, 2024
- Stage Public
-
Sectors
Chemicals & MaterialsHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bloomage Biotechnology Corp. Ltd. Class A
-
Annual Revenue
$727.46 M (USD)-11.71as on Dec 31, 2024
-
Net Profit
$23.87 M (USD)-70.59as on Dec 31, 2024
-
EBITDA
$75.9 M (USD)-35.61as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
4440
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bloomage Biotechnology
Bloomage Biotechnology is a publicly listed company on the SSE with ticker symbol 688363 in China, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Bloomage Biotechnology
Detailed funding history for Bloomage Biotechnology
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bloomage Biotechnology
Bloomage Biotechnology has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Beijing Yierkang Bioengineering.
Investment portfolio details for Bloomage Biotechnology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturer of artificial bone and collagen sponge
|
Locked | Locked | 1997 | Locked |
Complete acquisition details for Bloomage Biotechnology
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Bloomage Biotechnology
Detailed financials for Bloomage Biotechnology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bloomage Biotechnology Comparisons
Peer comparison for Bloomage Biotechnology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bloomage Biotechnology
Bloomage Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fidia Farma, Lifecore, Contipro, Qingdao Kangyuan Pharmaceutica and Altergon Italia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Proprietary hyaluronic acid treatments and derivatives are developed.
|
|
| Locked | Locked | Locked |
Hyaluronan-based products for biomedical applications are developed.
|
|
| Locked | Locked | Locked |
Manufacturer of hyaluronic acid-based products
|
|
| Locked | Locked | Locked |
Operates as a CDMO specializing in hyaluronidase manufacturing.
|
|
| Locked | Locked | Locked |
Develops and manufactures pharmaceutical products and medical devices for clients.
|
Detailed competitors of Bloomage Biotechnology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bloomage Biotechnology
Complete news archive for Bloomage Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bloomage Biotechnology
Bloomage Biotechnology was founded in 1998.
Bloomage Biotechnology is headquartered in Jinan, China. It is registered at Jinan, Shandong, China.
Zhao Yan is the current CEO of Bloomage Biotechnology.
As of Dec 31, 2024, the latest employee count at Bloomage Biotechnology is 4,440.
Annual revenue of Bloomage Biotechnology is $727.46M as on Dec 31, 2024.
Founded in 1998 in Jinan, China, operations are focused on the biotechnology sector, where hyaluronic acid and pharmaceutical products are produced. Additional manufacturing includes cosmetic and food-grade products, as well as bioactive materials. Technical support is provided to clients. The company serves global markets through its domain, bloomagebioactive.com, with leadership held by CEOs Zhao Yan and Xue Kun Jin.
Bloomage Biotechnology's top competitors include Lifecore, Fidia Farma and Contipro.
Yes, Bloomage Biotechnology is publicly traded on SSE under the ticker symbol 688363.
Bloomage Biotechnology has made 1 acquisition, including Beijing Yierkang Bioengineering.
The ticker symbol of Bloomage Biotechnology is 688363 on SSE.